{"disease":{"id":"progressive-massive-fibrosis","name":"progressive massive fibrosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05118256","title":"Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"Instituto de investigación e innovación biomédica de Cádiz","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}